|
Characteristic
|
Total sample N = 450
|
Female n = 356
|
Male n = 94
|
|---|
|
Age group
|
|
18–24 years
|
20 (4.4%)
|
11 (3.1%)
|
9 (9.6%)
|
|
25–35 years
|
87 (19.3%)
|
79 (22.2%)
|
8 (8.5%)
|
|
36–49 years
|
223 (49.6%)
|
175 (49.2%)
|
48 (51.1%)
|
|
50–60 years
|
120 (26.7%)
|
91 (25.6%)
|
29 (30.9%)
|
|
Marital status
|
|
Married/cohabiting
|
196 (43.6%)
|
142 (39.9%)
|
54 (57.5%)
|
|
Separated/divorced/widowed
|
197 (43.8%)
|
173 (48.6%)
|
24 (25.5%)
|
|
Never married
|
57 (12.7%)
|
41 (11.5%)
|
16 (17.0%)
|
|
Education
|
|
Tertiary
|
22 (4.9%)
|
13 (3.7%)
|
9 (9.6%)
|
|
Secondary
|
66 (14.7%)
|
42 (11.8%)
|
24 (25.5%)
|
|
Primary
|
239 (53.1%)
|
180 (50.6%)
|
59 (62.8%)
|
|
None
|
123 (27.3%)
|
121 (34.0%)
|
2 (2.1%)
|
|
Employment
|
|
Formally employed
|
53 (11.8%)
|
34 (9.6%)
|
19 (20.2%)
|
|
Self-employed
|
117 (26.0%)
|
95 (26.7%)
|
22 (23.4%)
|
|
Unemployed
|
269 (59.8%)
|
219 (61.5%)
|
50 (53.2%)
|
|
Other
|
11 (2.4%)
|
8 (2.3%)
|
3 (3.2%)
|
|
Current chronic medical illnessa
|
|
Present
|
37 (8.2%)
|
30 (8.4%)
|
7 (7.5%)
|
|
Not present
|
413 (91.8%)
|
326 (91.6%)
|
87 (92.6%)
|
|
Antiretroviral regimenb
|
|
First line
|
425 (95.3%)
|
335 (95.2%)
|
90 (95.7%)
|
|
Second line
|
21 (4.7%)
|
17 (4.8%)
|
4 (4.3%)
|
|
WHO disease staging
|
|
Stage 1
|
417 (93.7%)
|
334 (94.9%)
|
83 (89.3%)
|
|
Stage 2
|
22 (4.9%)
|
14 (4.0%)
|
8 (8.6%)
|
|
Stage 3
|
3 (0.7%)
|
2 (0.6%)
|
1 (1.1%)
|
|
Stage 4
|
3 (0.7%)
|
2 (0.6%)
|
1 (1.1%)
|
- All variables had complete data except for antiretroviral regimen (4 missing observations) and WHO disease staging (5 missing observations)
- aBased on client self-reporting as informed by their clinician
- bAll the 21 participants on second-line medication were initially started on first line
